Gastrointestinal pain in functional bowel disorders: sensory neurons as novel drug targets

JOURNAL ARTICLE published 2004 in Expert Opinion on Therapeutic Targets

Authors: Peter Holzer

Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects

JOURNAL ARTICLE published 2003 in Expert Opinion on Therapeutic Targets

Authors: Barbara Fingleton

11?-Hydroxysteroid dehydrogenase Type 1 as a novel therapeutic target in metabolic and neurodegenerative disease

JOURNAL ARTICLE published 2003 in Expert Opinion on Therapeutic Targets

Authors: Brian R Walker | Jonathan R Seckl

Selective genetic analysis of myoma pseudocapsule and potential biological impact on uterine fibroid medical therapy

JOURNAL ARTICLE published 2 January 2015 in Expert Opinion on Therapeutic Targets

Authors: Silvia Di Tommaso | Serafina Massari | Antonio Malvasi | Daniele Vergara | Michele Maffia | Marilena Greco | Andrea Tinelli

Emerging therapeutic targets in chronic heart failure: Part II

JOURNAL ARTICLE published 2003 in Expert Opinion on Therapeutic Targets

Authors: Volker Roenicke | St�phane Leclair | Anke Hoffmann | Michael Becker | Tania Szado | Thomas Kirsch | Oliver Stoss | Barbara T Nav� | Thomas Henkel

Why is the Plasmodium falciparum hexose transporter a promising new drug target?

JOURNAL ARTICLE published 2003 in Expert Opinion on Therapeutic Targets

Authors: T Jo�t | C Morin | J Fischbarg | Abraham I Louw | U Eckstein-Ludwig | C Woodrow | S Krishna

HIV-1 entry inhibitors: closing the front door

JOURNAL ARTICLE published 2004 in Expert Opinion on Therapeutic Targets

Authors: Brian Tomkowicz | Ronald G Collman

Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease

JOURNAL ARTICLE published January 2014 in Expert Opinion on Therapeutic Targets

Authors: Silvia Montoro-García | Eduard Shantsila | Gregory YH Lip

p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes

JOURNAL ARTICLE published December 2016 in Expert Opinion on Therapeutic Targets

Research funded by National Institute of Child Health and Human Development (1R03HD08635401) | March of Dimes, Ohio (Innovative Catalyst Grant)

Authors: Ramkumar Menon | John Papaconstantinou

Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis

JOURNAL ARTICLE published September 2009 in Expert Opinion on Therapeutic Targets

Authors: Mehtap Cakir | Ashley B Grossman

MYC, MYCL, and MYCN as therapeutic targets in lung cancer

JOURNAL ARTICLE published 1 February 2020 in Expert Opinion on Therapeutic Targets

Authors: Daniel Massó-Vallés | Marie-Eve Beaulieu | Laura Soucek

Mast cells in health and disease: from basic science to clinical application

JOURNAL ARTICLE published December 2008 in Expert Opinion on Therapeutic Targets

Authors: Dennis Kirchhoff | Stephan C Bischoff | Marcus Maurer | Thomas M Zollner

Regeneration following spinal cord injury, from experimental models to humans: where are we?

JOURNAL ARTICLE published June 2006 in Expert Opinion on Therapeutic Targets

Authors: Simone Di Giovanni

Scavenger receptor A in immunity and autoimmune diseases: Compelling evidence for targeted therapy

JOURNAL ARTICLE published 4 May 2022 in Expert Opinion on Therapeutic Targets

Authors: Yang Xie | Yuan Jia | Zhanguo Li | Fanlei Hu

Non-cell-autonomous signaling by Shh in tumors: challenges and opportunities for therapeutic targets

JOURNAL ARTICLE published July 2010 in Expert Opinion on Therapeutic Targets

Authors: Maarten F Bijlsma | Henk Roelink

Cyclin-dependent kinases and stroke

JOURNAL ARTICLE published October 2001 in Expert Opinion on Therapeutic Targets

Authors: David S Park | Fuhu Wang | Michael J O’Hare

Galectin-3: therapeutic targeting in liver disease

JOURNAL ARTICLE published 2 September 2023 in Expert Opinion on Therapeutic Targets

Authors: Alison C. Mackinnon | Dimitar Tonev | Brian Jacoby | Massimo Pinzani | Robert J. Slack

Use of LHRH-agonists as adjuvant therapy for breast cancer

JOURNAL ARTICLE published August 2008 in Expert Opinion on Therapeutic Targets

Authors: Jack Cuzick

Heat shock protein 70 – the next chaperone to target in the treatment of human acute myelogenous leukemia?

JOURNAL ARTICLE published August 2014 in Expert Opinion on Therapeutic Targets

Authors: Håkon Reikvam | Annette K Brenner | Ina Nepstad | André Sulen | Øystein Bruserud

The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome

JOURNAL ARTICLE published December 2012 in Expert Opinion on Therapeutic Targets

Authors: Andréa Name Colado Simão | Marcell Alysson Batisti Lozovoy | Isaias Dichi